Sensus Healthcare Resumes Common Stock Repurchase Program
On February 11, 2025, Sensus Healthcare, Inc. (NASDAQ: SRTS) announced the revival of its common stock repurchase program, initially authorized in August 2023. The company, based in Boca Raton, Florida, specializes in medical device solutions focused on minimally invasive treatments for oncological and non-oncological skin conditions. The decision to restart the repurchase program was unveiled […]
On February 11, 2025, Sensus Healthcare, Inc. (NASDAQ: SRTS) announced the revival of its common stock repurchase program, initially authorized in August 2023. The company, based in Boca Raton, Florida, specializes in medical device solutions focused on minimally invasive treatments for oncological and non-oncological skin conditions. The decision to restart the repurchase program was unveiled […]
